Test product 1 for Beverage Hydration Index

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Lipscomb University, Nashville, TN
Beverage Hydration Index+2 More
Test product 1 - Other
Eligibility
18 - 65
Male
What conditions do you have?
Select

Study Summary

Dehydration lowers both physical and mental performance if it is severe enough. Performance declines are more pronounced in hot conditions or after prolonged strenuous activity such as exercise. Most individuals drink less than their sweat losses during activity, while some individuals overdrink and develop a sodium deficiency. Water and electrolyte balance must be restored as part of the recovery process after any activity that causes sweating. Plain water causes a decrease in plasma sodium concentration and osmolality, which reduces the desire to drink and increases urine production. Unless the volume ingested exceeds the loss, individuals are in net negative fluid balance throughout the recovery period due to urinary losses. When sodium and potassium are added to rehydration fluids, urine production is reduced in the hours following rehydration. Rehydration is only possible if a volume of fluid equal to or greater than the amount lost through sweat is consumed, together with adequate electrolytes. The two test products for this study, are novel hydration beverage formulas. They are an electrolyte drink mixture with five essential vitamins and three times more electrolytes than typical sports beverages. The test products create an osmotic force that permits water to be supplied to the bloodstream sooner in the digestive system by using a specific ratio of sodium, glucose, and potassium. This randomized, placebo-controlled, semi-blind, crossover study will evaluate the effects of the test products on rehydration in healthy adults.

Eligible Conditions

  • Beverage Hydration Index
  • Fluid Retention
  • Hydration Status

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Beverage Hydration Index

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: Through study completion, average of 6 weeks

Week 6
Beverage hydration index
Hydration status

Trial Safety

Safety Progress

1 of 3

Other trials for Beverage Hydration Index

Trial Design

3 Treatment Groups

Test Product 2
1 of 3
Test Product 1
1 of 3
Placebo
1 of 3
Experimental Treatment
Non-Treatment Group

15 Total Participants · 3 Treatment Groups

Primary Treatment: Test product 1 · Has Placebo Group · N/A

Test Product 2
Other
Experimental Group · 1 Intervention: Test product 2 · Intervention Types: Other
Test Product 1
Other
Experimental Group · 1 Intervention: Test product 1 · Intervention Types: Other
Placebo
Other
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: through study completion, average of 6 weeks
Closest Location: Lipscomb University · Nashville, TN
Photo of Nashville 1Photo of Nashville 2Photo of Nashville 3
2018First Recorded Clinical Trial
1 TrialsResearching Beverage Hydration Index
1 CompletedClinical Trials

Who is running the clinical trial?

Lipscomb UniversityOTHER
4 Previous Clinical Trials
73 Total Patients Enrolled
Liquid I.V.Lead Sponsor
3 Previous Clinical Trials
72 Total Patients Enrolled
Jeremy Townsend, PhDPrincipal InvestigatorLipscomb University
1 Previous Clinical Trials
11 Total Patients Enrolled

Eligibility Criteria

Age 18 - 65 · Male Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.